Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

VTF:GR

17.790 EUR 0.135 0.75%

As of 13:15:48 ET on 02/27/2015.

Snapshot for Vitrolife AB (VTF)

Open: 17.718 Day's Range: 17.528 - 17.890 Volume: 0
Previous Close: 17.925 52wk Range: 9.945 - 19.440 1-Yr Rtn: +58.75%

Stock Chart for VTF

No chart data available.
  • VTF:GR 17.790
  • 1D
  • 1M
  • 1Y
17.925
Interactive VTF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VTF

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 32.9476
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2015) 5.0500
Est. PEG Ratio -
Market Cap (M EUR) 386.22
Shares Outstanding (M) 21.71
30 Day Average Volume 149
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.90%
Cash Dividend (SEK) 1.5000
Dividend Ex-Date 05/06/2015
5 Year Dividend Growth 24.22%
Next Earnings Announcement 04/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VTF

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for VTF

Vitrolife AB is an international biotechnology corporation. The Company develops, produces, and markets products for creating, prolonging, and improving life. Vitrolife focuses on fertility treatments, cell therapy and tissue engineering, organ transplantation systems, and products base on hyaluronic acid. The Company researches and manufactures in Europe and the United States.

Thomas AxelssonChief Executive OfficerMikael EngblomChief Financial Officer
Christer SilversandChief Scientific OfficerMaria ForssVP:Business Development/Mktg
More Company Profile & Key Executives for VTF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil